Gabor Than Award Lecture 2008: Pre-eclampsia - From Placental Oxidative Stress to Maternal Endothelial Dysfunction

Placenta

Volumn 30, Issue SUPPL., 2009, Pages 55-65

  Cindrova Davies, T ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endothelial dysfunction; Inflammation; Oxidative stress; Pre eclampsia; Signalling pathways

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; FIBROBLAST GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CLINICAL TRIAL; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; FETUS MORTALITY; HUMAN; INFLAMMATION; ISCHEMIA; LABOR; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNAL WELFARE; NONHUMAN; OXIDATIVE STRESS; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION; SIGNAL TRANSDUCTION; SMALL FOR DATE INFANT; VITAMIN SUPPLEMENTATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIOXIDANTS; APOPTOSIS; ENDOPLASMIC RETICULUM; ENDOTHELIUM; FEMALE; HUMANS; INFLAMMATION; NF-KAPPA B; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 60249102684     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.11.020     Document Type: Article

References (81)

1. Redman C.W.G., and Sargent I.L. Placental debris, oxidative stress and pre-eclampsia. Placenta 21 (2000) 597-602
2. Roberts J.M., and Lain K.Y. Recent insights into the pathogenesis of pre-eclampsia. Placenta 23 (2002) 359-372
3. Mutter W.P., and Karumanchi S.A. Molecular mechanisms of preeclampsia. Microvasc Res 75 (2008) 1-8
4. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
5. Burton G.J., and Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 11 (2004) 342-352
6. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 5-15
7. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
8. Nathan C., and Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 97 (2000) 8841-8848
9. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
10. Trachootham D., Lu W., Ogasawara M.A., Nilsa R.D., and Huang P. Redox regulation of cell survival. Antioxid Redox Signal 10 (2008) 1343-1374
11. Myatt L., Rosenfield R.B., Eis A.L., Brockman D.E., Greer I., and Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28 (1996) 488-493
12. Brosens J.J., Pijnenborg R., and Brosens I.A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187 (2002) 1416-1423
13. Jauniaux E., Ramsay B., and Campbell S. Ultrasonographic investigation of placental morphologic characteristics and size during the second trimester of pregnancy. Am J Obstet Gynecol 170 (1994) 130-137
14. Jauniaux E., Jurkovic D., and Campbell S. Current topic: in vivo investigation of the placental circulations by Doppler echography. Placenta 16 (1995) 323-331
15. Burton G.J. Hung T-H. Hypoxia-reoxygenation; a potential source of placental oxidative stress in normal pregnancy and preeclampsia. Fetal Maternal Med Rev 14 (2003) 97-117
16. Kaaja R., Tikkanen M.J., Viinikka L., and Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 85 (1995) 353-356
17. Sacks G.P., Studena K., Sargent K., and Redman C.W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179 (1998) 80-86
18. Redman C.W., Sacks G.P., and Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180 (1999) 499-506
19. Hubel C.A., Roberts J.M., Taylor R.N., Musci T.J., Rogers G.M., and McLaughlin M.K. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 161 (1989) 1025-1034
20. Haddad J.J. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 14 (2002) 879-897
21. Bourdon E., and Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 3 (2001) 293-311
22. England K., and Cotter T.G. Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis. Redox Rep 10 (2005) 237-245
23. Cross J.V., and Templeton D.J. Regulation of signal transduction through protein cysteine oxidation. Antioxid Redox Signal 8 (2006) 1819-1827
24. Chiarugi P. PTPs versus PTKs: the redox side of the coin. Free Radic Res 39 (2005) 353-364
25. Cho S.H., Lee C.H., Ahn Y., Kim H., Kim H., Ahn C.Y., et al. Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling. FEBS Lett 560 (2004) 7-13
26. Reinstein E., and Ciechanover A. Narrative review: protein degradation and human diseases: the ubiquitin connection. Ann Intern Med 145 (2006) 676-684
27. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81 (2001) 807-869
28. Matsuzawa A., and Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal 7 (2005) 472-481
29. Liu H., Nishitoh H., Ichijo H., and Kyriakis J.M. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 20 (2000) 2198-2208
30. Cindrova-Davies T., Spasic-Boskovic O., Jauniaux E., Charnock-Jones D.S., and Burton G.J. NF-κB, p38 and stress activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress. Am J Path 170 (2007) 1511-1520
31. Cook S.A., Sugden P.H., and Clerk A. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol 31 (1999) 1429-1434
32. Cain B.S., Meldrum D.R., Meng X., Dinarello C.A., Shames B.D., Banerjee A., et al. p38 MAPK inhibition decreases TNF-alpha production and enhances postischemic human myocardial function. J Surg Res 83 (1999) 7-12
33. Leslie N.R. The redox regulation of PI 3-kinase-dependent signaling. Antioxid Redox Signal 8 (2006) 1765-1774
34. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 (1996) 619-628
35. Lawlor M.A., and Alessi D.R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J Cell Sci 114 (2001) 2903-2910
36. Yung H.W., Calabrese S., Hynx D., Hemmings B.A., Cetin I., Charnock-Jones D.S., et al. Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol 173 (2008) 451-462
37. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
38. Hajra L., Evans A.I., Chen M., Hyduk S.J., Collins T., and Cybulsky M.I. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A 97 (2000) 9052-9057
39. 2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am J Physiol Heart Circ Physiol 293 (2007) H37-H47
40. Xu C., Bailly-Maitre B., and Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115 (2005) 2656-2664
41. Cullinan S.B., and Diehl J.A. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int J Biochem Cell Biol 38 (2006) 317-332
42. Yoshida H. ER stress and diseases. FEBS J 274 (2007) 630-658
43. Zhang K., and Kaufman R.J. From endoplasmic-reticulum stress to the inflammatory response. Nature 454 (2008) 455-462
44. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313 (2006) 1137-1140
45. Luppi P., Tse H., Lain K.Y., Markovic N., Piganelli J.D., and DeLoia J.A. Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol 56 (2006) 135-144
46. McCracken S.A., Drury C.L., Lee H.S., and Morris J.M. Pregnancy is associated with suppression of the nuclear factor kappaB/IkappaB activation pathway in peripheral blood mononuclear cells. J Reprod Immunol 58 (2003) 27-47
47. Shah T.J., and Walsh S.W. Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia. Am J Obstet Gynecol 196 48 (2007) e1-e8
48. Takacs P., Kauma S.W., Sholley M.M., Walsh S.W., Dinsmoor M.J., and Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 15 (2001) 279-281
49. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
50. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
51. Brar H., and Einarson A. Effects and treatment of inflammatory bowel disease during pregnancy. Can Fam Physician 54 (2008) 981-983
52. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., and Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361 (2003) 2017-2023
53. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293 (2005) 1338-1347
54. Poston L., Briley A.L., Seed P.T., Kelly F.J., and Shennan A.H. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367 (2006) 1145-1154
55. Rumbold A.R., Crowther C.A., Haslam R.R., Dekker G.A., and Robinson J.S. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354 (2006) 1796-1806
56. Catov J.M., Bodnar L.M., Ness R.B., Markovic N., and Roberts J.M. Association of periconceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am J Epidemiol 166 (2007) 296-303
57. Haugen M., Meltzer H.M., Brantsaeter A.L., Mikkelsen T., Osterdal M.L., Alexander J., et al. Mediterranean-type diet and risk of preterm birth among women in the Norwegian Mother and Child Cohort Study (MoBa): a prospective cohort study. Acta Obstet Gynecol Scand 87 (2008) 319-324
58. Aravanis C., Corcondilas A., Dontas A.S., Lekos D., and Keys A. Coronary heart disease in seven countries. IX. The Greek islands of Crete and Corfu. Circulation 41 (1970) I88-I100
59. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., and Yodoi J. Redox control of cell death. Antioxid Redox Signal 4 (2002) 405-414
60. Shen H.M., and Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20 (2006) 1589-1598
61. Leung D.N., Smith S.C., To K.F., Sahota D.S., and Baker P.N. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 184 (2001) 1249-1250
62. Schrocksnadel H., Daxenbichler G., Artner E., Steckel-Berger G., and Dapunt O. Tumor markers in hypertensive disorders of pregnancy. Gynecol Obstet Invest 35 (1993) 204-208
63. Lo Y.M., Leung T.N., Tein M.S., Sargent I.L., Zhang J., Lau T.K., et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45 (1999) 184-188
64. Knight M., Redman C.W., Linton E.A., and Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 105 (1998) 632-640
65. Tjoa M.-L., Cindrova-Davies T., Spasic-Boskovic O., Bianchi D.W., and Burton G.J. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Path 169 (2006) 400-404
66. Hung T.H., Skepper J.N., Charnock-Jones D.S., and Burton G.J. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90 (2002) 1274-1281
67. Cindrova-Davies T., Yung H.W., Johns J., Spasic-Boskovic O., Korolchuk S., Jauniaux E., et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol 171 (2007) 1168-1179
68. Germain S.J., Sacks G.P., Sooranna S.R., Sargent I.L., and Redman C.W. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178 (2007) 5949-5956
69. Jung Y.-J., Isaacs J.S., Lee S., Trepel J., and Neckers L. IL-1β mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17 (2003) 2115-2117
70. Jung Y.-J., Isaacs J.S., Lee S., Trepel J., Liu Z.G., and Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappaB activation. Biochem J 370 (2003) 1011-1017
71. Jung Y.-J., Isaacs J.S., Lee S., Trepel J., and Neckers L. Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein. J Biol Chem 278 (2003) 7445-7452
72. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
73. Schnabel R., Blankenberg S., Lubos E., Lackner K.J., Rupprecht H.J., Espinola-Klein C., et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97 (2005) e53-e59
74. Savvidou M.D., Hingorani A.D., Tsikas D., Frolich J.C., Vallance P., and Nicolaides K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361 (2003) 1511-1517
75. Kim Y.J., Park H.S., Lee H.Y., Ha E.H., Suh S.H., Oh S.K., et al. Reduced l-arginine level and decreased placental eNOS activity in preeclampsia. Placenta 27 (2006) 438-444
76. Orange S.J., Painter D., Horvath J., Yu B., Trent R., and Hennessy A. Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia. Clin Exp Pharmacol Physiol 30 (2003) 376-381
77. Napolitano M., Miceli F., Calce A., Vacca A., Gulino A., Apa R., et al. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J Clin Endocrinol Metab 85 (2000) 2318-2323
78. Yoshimura T., Yoshimura M., Tabata A., Shimasaki Y., Nakayama M., Miyamoto Y., et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig 7 (2000) 238-241
79. Sokolovsky M. Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol Ther 68 (1995) 435-471
80. Nova A., Sibai B.M., Barton J.R., Mercer B.M., and Mitchell M.D. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 165 (1991) 724-727
81. Greenberg S.G., Baker R.S., Yang D., and Clark K.E. Effects of continuous infusion of endothelin-1 in pregnant sheep. Hypertension 30 (1997) 1585-1590